AGC Biologics Expands Cell Therapy Suites at Longmont ATMP Campus
SEATTLE, August 23, 2023--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a capacity update with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.
Baden Wüberg United States Whitney Sandberg Biologics Longmont Biopharmaceutical Contract Development Contract Development
Source: yahoo.com